Ohm, question. Two MOAs at play here - CCR5
Post# of 148170
Two MOAs at play here
- CCR5 antagonism, and
- Macrophage phenotype re-polarization
I recall that Leronlimab has been attributed 4 Mechanisms of Action.
I can name 1 more MOA
- Stopping Angiogenesis (blood supply creation in tumors)
What’s the fourth MOA??